<DOC>
	<DOCNO>NCT02356081</DOCNO>
	<brief_summary>Chemotherapy may cause distress symptom impact patient ' quality life . Chemotherapy frequently give outpatient basis therefore patient often required manage symptom experience home without direct supervision healthcare professional . This study aim evaluate impact mobile phone base , remote monitoring , symptom management system ( ASyMS ) delivery care people nonmetastatic breast , colorectal haematological cancer chemotherapy one year follow treatment . The study aim compare number outcome patient use ASyMS intervention outcomes patient receive normal care hospital . Throughout chemotherapy treatment , day time feel unwell , patient allocate mobile phone group enter information phone regard symptom experience , take temperature enter phone . The information send via secure connection computer , assess information sends alert health care professional hospital , call patient home patient report problematic symptom . Patients normal care group receive care normal hospital . Both group patient ask complete series questionnaire start treatment , chemotherapy cycle 3 , 6 , 9 , 12 month treatment completion ( subset patient also ask complete midcycle symptom assessment ) . The study also evaluate cost benefit ASyMS , ass change clinical practice result ASyMS develop predictive risk model ( statistical model ) use future care patient receive chemotherapy cancer . This multicentre study take place across number European country .</brief_summary>
	<brief_title>eSMART Trial Evaluate ASyMS</brief_title>
	<detailed_description />
	<criteria>Diagnosed breast cancer , colorectal cancer , haematological malignancy ( i.e . HD NHL ) . Scheduled receive firstline cytotoxic chemotherapy . Scheduled receive 2 , 3 4weekly chemotherapy protocol ( i.e . chemotherapy administer repeated cycle 14 , 21 28 day , respectively ) . Planned receive minimum 3 chemotherapy cycle . Deemed physically/psychologically fit participate study member multidisciplinary team . Able understand communicate respective language . Diagnosed distant metastasis , i.e . stage IV disease define TNM/UICC ( breast colorectal cancer ) Ann Arbor Staging System ( NHL/HD ) . Patients metastatic disease exclude difference symptom profile experience people localise compare advanced disease [ 42 ] . Scheduled receive concurrent radiotherapy chemotherapy treatment . Scheduled receive weekly chemotherapy protocol . Also , patient shift 2 , 3 4weekly protocol weekly protocol chemotherapy exclude participation study . Diagnosed ( i.e . relapse occur ) another type cancer past . Having receive chemotherapy treatment past another type cancer . Unable provide write informed consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>